Literature DB >> 485189

Cutaneous manifestations of tumoral calcinosis.

T V Pursley, M J Prince, A B Chausmer, S S Raimer.   

Abstract

We have followed up a large family in which seven members have tumoral calcinosis. One girl had the skin lesions of localized calcinosis cutis apart from the typical subcutaneous deposits of calcium. Like most persons with tumoral calcinosis, our patient had normal serum calcium concentrations; however, the serum phosphorus levels were greatly elevated. The familial occurrence and elevated serum phosphorus levels suggest the possibility of some as yet undefined, heritable metabolic defect as the underlying cause. The occurrence of tumoral calcinosis with localized calcinosis cutis is a rare association, and there has been only one other reported case to our knowledge. This report describes our patient and offers a brief discussion of tumoral calcinosis. The therapeutic response to the phosphate depletion regimen and topical steroids was disappointing in our case.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 485189

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  4 in total

1.  Tumoral calcinosis revisited--common and uncommon features. Report of ten cases and review.

Authors:  A Metzker; B Eisenstein; J Oren; R Samuel
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

2.  Crystal-phagocyte interaction in calcinosis interstitialis.

Authors:  R E Schopf
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

Review 3.  Dystrophic calcinosis with both a huge calcified mass in the cervical spine and calcification in the chest wall in a patient with rheumatoid overlap syndrome.

Authors:  Tadashi Nakamura; Kei Hirakawa; Hirokazu Takaoka; Ken-Ichi Iyama
Journal:  Clin Rheumatol       Date:  2014-06-04       Impact factor: 2.980

4.  Idiopathic calcinosis cutis.

Authors:  Padmavathy Lanka; Lakshmana Rao Lanka; N Ethirajan; B Krishnaswamy; U Manohar
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.